Interesting Company Set aside the evident cash on hand problem, this company is more than viable for a less than 500k market cap stock. Low number of s/o and growth potential. Last update they said that the signed contracts from new clients increased and the company forecasts increased revenues for next three quarters. “Contract research revenue for the second half of 2014 will be strong"
By looking at their 3 last quarters, it is evident that they feel the cash flow pressure and are controlling costs. We will see if they are able to pull it off in Q4 (coming out soon).
Ultra speculative stock with growth potential on their contract research segment and we might have a surprise on the licensed product/technology side. The company burned a lot of cash on patents... hopefully it will pay off.
GLTA